Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProGastro CD
- Development stage
- Unknown
- Lead developer
- Prodesse
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ProGastro CD is a veterinary-specific pharmaceutical product containing omeprazole, a substituted benzimidazole that functions as a potent proton pump inhibitor (PPI). Developed by Richmond Vet Pharma, it is specifically formulated as enteric-coated microgranules within capsules to protect the acid-labile active ingredient from degradation in the stomach, ensuring optimal absorption in the small intestine. It is primarily indicated for the treatment and prevention of gastric ulcers, erosive gastritis, and esophagitis in horses, dogs, and cats. Mechanistically, omeprazole irreversibly binds to the H+/K+ ATPase enzyme system (the proton pump) at the secretory surface of gastric parietal cells, effectively blocking the final step of hydrochloric acid production. This results in a significant and prolonged reduction in both basal and stimulated gastric acid secretion, facilitating the healing of the gastric mucosa.
- Brand names
- ProGastro CD
- Other names
- omeprazole
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on ProGastro CD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProGastro CD.